|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
8/17/2009 1:27:55 PM
Cypress, CA / August 17, 2009 / - West Coast Clinical Trials (WCCT) has achieved an important milestone in its continually expanding Phase I study offerings. WCCT has successfully completed its first Phase I study in dialysis patients with 100% of the target enrollment achieved in only two weeks. This rapid enrollment allowed the sponsor to complete the clinical phase of the study three months ahead of schedule. WCCT added over 300 active dialysis patients to its database from two local dialysis centers. WCCT, a world-class provider of Phase I and Phase II/III clinical studies specializes in a number of study types involving normal healthy volunteers, special populations and a variety of patients.
About West Coast Clinical Trials, LLC
WCCT is an independent early phase clinical CRO with a 120-bed telemetry equipped Phase I facility located in Southern California. WCCT has a unique focus on Ethno-bridging studies along with extensive experience with healthy volunteer and specialty trials (allergy, asthma, infectious disease, pediatric, renal and vaccines). For more information, visit our Web site at http://www.wcctrials.com.
|
|
|
|
|
|
|
|
|
|
|